Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
HOTH
HOTH
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
HOTH News
Hoth Therapeutics Shares Surge 55% on Positive HT-VA Study Results
6d ago
NASDAQ.COM
REPL Faces Pressure After FDA Issues Second Complete Response Letter
6d ago
stocktwits
HT-VA Drug Outperforms Novo Nordisk in Key Metabolic Markers
6d ago
stocktwits
GDNF Shows Promise as Next-Gen Therapy for MAFLD and Obesity
6d ago
PRnewswire
GDNF Shows Promise as Next-Gen Therapy for MAFLD and Obesity
6d ago
Newsfilter
Hoth Therapeutics Closes Registered Direct Offering
Apr 02 2026
PRnewswire
Hoth Therapeutics Secures $2 Million Financing Through Share Offering
Apr 02 2026
NASDAQ.COM
Hoth Therapeutics Announces Stock Offering and Warrants Sale
Apr 01 2026
Newsfilter
Hoth Therapeutics Completes Stock Offering Agreement
Apr 01 2026
PRnewswire
Hoth Therapeutics Reports Positive Clinical Results for HT-001 Program
Apr 01 2026
PRnewswire
Hoth Therapeutics Launches AI Drug Development Platform OpenClaw™
Mar 26 2026
PRnewswire
Hoth Therapeutics Launches AI Drug Development Platform OpenClaw™
Mar 26 2026
Newsfilter
Hoth Therapeutics Reports Positive Data for HT-001
Mar 24 2026
PRnewswire
Hoth Therapeutics Reports Positive Data for HT-001
Mar 24 2026
Newsfilter
Hoth Therapeutics Advances GDNF for Metabolic Dysfunction
Mar 10 2026
PRnewswire
Hoth Therapeutics Integrates AI for IND Preparation and Phase 1 Progression
Mar 04 2026
PRnewswire
Show More News
